Searched for
MSN PHARMA
Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...- Natco beats rivals with Rs 1,290 semaglutide launch as Novo Nordisk patent expiresNatco Pharma introduces a new, affordable semaglutide injection in multidose vials. This launch coincides with the patent expiry of the inn...
- Three-day pharma industry event from Nov 25 to host global pharma leaders, exhibitors, investorsIndia's pharmaceutical industry total market size is projected to reach $130 billion by 2030 and an impressive $450 billion by 2047, highli...
- Trump’s immigration push backfires and faces major backlash - ICE arrests plunge 20% in JulyImmigration arrests in the United States saw a decline in July 2025. This happened despite President Trump's efforts to increase them. Data...
- Weight is over! Pharma companies race to make weight-loss drug semaglutideIndian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic vers...
- Boehringer Ingelheim obtains interim injunction against four Indian drug cos from selling its diabetes drugBI said the injunctions restrain the domestic pharma companies from infringing the patent of Linagliptin by advertising, launching, making,...
- MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brandThe group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facil...
- Govt panel weighing risks and benefits of Merck's Covid drugThe Subject Expert Committee (SEC) under the drug regulator of India has asked manufacturers in India to specify the category of Covid pati...
- USFDA approves COVID antiviral pill molnupiravir for emergency useThe USFDA also said the drug should be given for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or cl...
- SEC to review companies' applications for Molnupiravir on MondayThe drug is touted as a game-changer in the fight against the pandemic, and a panel of experts of the US Food and Drug Administration (FDA)...
- Expert panel asks drug cos to submit subgroup data on MolnupiravirMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Expert panel seeks additional info on Merck's Covid-19 drugMolnupiravir is the first oral antiviral approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of...
- Panel to meet today to take up applications seeking nod for MolnupiravirThe firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other...
- MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battleEarlier, ET reported that Dr Reddy's Labs has launched copies of Jardiance. It has a valid patent in India until 2025.
- Aurobindo Pharma, MSN Labs seek DGCI nod for Phase-III trials of Merck's molnupiravirIn a meeting held on October 4, both the companies said that they “they want to discontinue phase III trial in moderate Covid-19 patients a...
- Two Indian drugmakers seek to end trials of Merck's antiviral drug for moderate COVID-19The two Indian drugmakers, Aurobindo Pharma and MSN Laboratories plan to continue late-stage trails of the drug for those with mild COVID-1...
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- MSN Laboratories to foray into pain management market with launch of painkiller 'Tapentadol'MSN Laboratories Limited, will foray into the pain management market with the launch of 'Tapentadol' a pain killer under brand name Tapal i...
- Entrepreneurship bug bites pharma, biotech execsSenior professionals have earned enough expertise to start their own ventures at a time when the market and funding options are favourable.
- Pillion ride to etrepreneurshipProfessionals in pharma and biotechnology companies are increasingly taking the plunge to set up start-ups - a trend which investors descri...
Load More
